|
OBSV
|
ObsEva SA
|
US
|
NASDAQ
|
|
OCC
|
Orthocell Ltd
|
AU
|
ASX
|
|
OCEA
|
Ocean Biomedical Inc.
|
US
|
US
|
|
OCEAW
|
Ocean Biomedical Inc.
|
US
|
US
|
|
OCGN
|
Ocugen, Inc.
|
US
|
NASDAQ
|
|
OCS
|
Oculis Holding AG Ordinary shares
|
US
|
US
|
|
OCSAW
|
Oculis Holding AG Warrants
|
US
|
US
|
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
|
OGEN
|
Oragenics, Inc.
|
US
|
AMEX
|
|
OKYO
|
Okyo Pharma Corporation
|
UK
|
LSE
|
|
OMMH
|
Omnimmune Holdings Inc
|
US
|
OTC
|
|
ONCO
|
Oncopeptides AB
|
SE
|
ST
|
|
ONCS
|
OncoSec Medical Incorporated
|
US
|
NASDAQ
|
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
|
ONVO
|
Organovo Holdings, Inc.
|
US
|
NASDAQ
|
|
ONWD
|
Onward Medical N.V.
|
BE
|
BR
|
|
OPGN
|
OpGen, Inc.
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
OPT
|
Opthea Ltd
|
AU
|
ASX
|